Barclays PLC grew its stake in Nano-X Imaging Ltd. (NASDAQ:NNOX - Free Report) by 258.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 86,181 shares of the company's stock after purchasing an additional 62,140 shares during the period. Barclays PLC owned about 0.15% of Nano-X Imaging worth $523,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. State Street Corp lifted its stake in Nano-X Imaging by 2.1% during the third quarter. State Street Corp now owns 983,305 shares of the company's stock worth $5,978,000 after purchasing an additional 20,279 shares during the period. The Manufacturers Life Insurance Company lifted its position in Nano-X Imaging by 14.8% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,210 shares of the company's stock worth $148,000 after buying an additional 2,600 shares in the last quarter. Verition Fund Management LLC bought a new stake in Nano-X Imaging during the 3rd quarter worth about $88,000. Van ECK Associates Corp increased its holdings in shares of Nano-X Imaging by 14.1% in the second quarter. Van ECK Associates Corp now owns 22,293 shares of the company's stock valued at $164,000 after purchasing an additional 2,755 shares in the last quarter. Finally, Creative Planning acquired a new stake in shares of Nano-X Imaging in the 3rd quarter valued at $107,000. Institutional investors own 21.49% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Cantor Fitzgerald raised their price target on Nano-X Imaging from $11.00 to $12.00 and gave the stock an "overweight" rating in a research report on Friday, December 6th.
Check Out Our Latest Analysis on Nano-X Imaging
Nano-X Imaging Price Performance
NNOX stock traded up $0.38 during trading hours on Friday, reaching $9.25. 7,925,454 shares of the stock were exchanged, compared to its average volume of 10,287,277. The company has a market cap of $534.46 million, a price-to-earnings ratio of -10.88 and a beta of 2.02. The firm's 50-day moving average is $6.62 and its 200-day moving average is $6.78. Nano-X Imaging Ltd. has a 12 month low of $5.26 and a 12 month high of $14.28.
Nano-X Imaging Company Profile
(
Free Report)
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Further Reading
Before you consider Nano-X Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.
While Nano-X Imaging currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
